These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


437 related items for PubMed ID: 18322255

  • 1. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
    Odièvre MH, Bony V, Benkerrou M, Lapouméroulie C, Alberti C, Ducrocq R, Jacqz-Aigrain E, Elion J, Cartron JP.
    Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
    [Abstract] [Full Text] [Related]

  • 2. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea.
    Cartron JP, Elion J.
    Transfus Clin Biol; 2008 Apr; 15(1-2):39-50. PubMed ID: 18515167
    [Abstract] [Full Text] [Related]

  • 3. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
    Gambero S, Canalli AA, Traina F, Albuquerque DM, Saad ST, Costa FF, Conran N.
    Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
    [Abstract] [Full Text] [Related]

  • 4. Role of Lu/BCAM in abnormal adhesion of sickle red blood cells to vascular endothelium.
    El Nemer W, Gauthier E, Wautier MP, Rahuel C, Gane P, Galactéros F, Wautier JL, Cartron JP, Colin Y, Le Van Kim C.
    Transfus Clin Biol; 2008 Feb; 15(1-2):29-33. PubMed ID: 18514010
    [Abstract] [Full Text] [Related]

  • 5. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [Abstract] [Full Text] [Related]

  • 6. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.
    Styles LA, Lubin B, Vichinsky E, Lawrence S, Hua M, Test S, Kuypers F.
    Blood; 1997 Apr 01; 89(7):2554-9. PubMed ID: 9116302
    [Abstract] [Full Text] [Related]

  • 7. B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease.
    Zen Q, Batchvarova M, Twyman CA, Eyler CE, Qiu H, De Castro LM, Telen MJ.
    Am J Hematol; 2004 Feb 01; 75(2):63-72. PubMed ID: 14755370
    [Abstract] [Full Text] [Related]

  • 8. Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease.
    Johnson C, Telen MJ.
    Haematologica; 2008 Apr 01; 93(4):481-5. PubMed ID: 18379005
    [No Abstract] [Full Text] [Related]

  • 9. Red cell and endothelial Lu/BCAM beyond sickle cell disease.
    Colin Y, Rahuel C, Wautier MP, El Nemer W, Filipe A, Cartron JP, Le Van Kim C, Wautier JL.
    Transfus Clin Biol; 2008 Dec 01; 15(6):402-5. PubMed ID: 18948049
    [Abstract] [Full Text] [Related]

  • 10. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
    Brun M, Bourdoulous S, Couraud PO, Elion J, Krishnamoorthy R, Lapoumeroulie C.
    Pharmacogenomics J; 2003 Dec 01; 3(4):215-26. PubMed ID: 12931135
    [Abstract] [Full Text] [Related]

  • 11. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation.
    Bartolucci P, Chaar V, Picot J, Bachir D, Habibi A, Fauroux C, Galactéros F, Colin Y, Le Van Kim C, El Nemer W.
    Blood; 2010 Sep 23; 116(12):2152-9. PubMed ID: 20566895
    [Abstract] [Full Text] [Related]

  • 12. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells.
    El Nemer W, Wautier MP, Rahuel C, Gane P, Hermand P, Galactéros F, Wautier JL, Cartron JP, Colin Y, Le Van Kim C.
    Blood; 2007 Apr 15; 109(8):3544-51. PubMed ID: 17158232
    [Abstract] [Full Text] [Related]

  • 13. Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation.
    Chaar V, Laurance S, Lapoumeroulie C, Cochet S, De Grandis M, Colin Y, Elion J, Le Van Kim C, El Nemer W.
    J Biol Chem; 2014 Apr 18; 289(16):11512-11521. PubMed ID: 24616094
    [Abstract] [Full Text] [Related]

  • 14. Role of Lu/BCAM glycoproteins in red cell diseases.
    El Nemer W, Colin Y, Le Van Kim C.
    Transfus Clin Biol; 2010 Sep 18; 17(3):143-7. PubMed ID: 20655789
    [Abstract] [Full Text] [Related]

  • 15. Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.
    Chaar V, Picot J, Renaud O, Bartolucci P, Nzouakou R, Bachir D, Galactéros F, Colin Y, Le Van Kim C, El Nemer W.
    Haematologica; 2010 Nov 18; 95(11):1841-8. PubMed ID: 20562314
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis of erythrocyte adhesion to endothelial cells in diseases.
    Wautier JL, Wautier MP.
    Clin Hemorheol Microcirc; 2013 Nov 18; 53(1-2):11-21. PubMed ID: 22941965
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Nov 18; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N, Fattori A, Saad ST, Costa FF.
    Am J Hematol; 2004 Aug 18; 76(4):343-7. PubMed ID: 15282666
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G.
    N Engl J Med; 1985 Dec 19; 313(25):1571-5. PubMed ID: 2415821
    [Abstract] [Full Text] [Related]

  • 20. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation.
    Canalli AA, Franco-Penteado CF, Saad ST, Conran N, Costa FF.
    Haematologica; 2008 Apr 19; 93(4):605-9. PubMed ID: 18326523
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.